by healthadvances Posted on September 18, 2018September 18, 2018 New Assessment Pathway for Invasive High-Risk Medical Devices in Germany: Balancing Market Access, Evidence and Patient Benefit Read More
by healthadvances Posted on August 23, 2018 Disease Management Programs (DMPs) in Germany: The Importance of Guideline Inclusion for Chronic Therapies Read More
by healthadvances Posted on August 1, 2018August 1, 2018 Putting Cerner’s Big Investment in Lumeris Into Strategic Context Read More
by healthadvances Posted on July 24, 2018 Join Health Advances at AACC for Our 10th Annual Cocktail Reception Read More
by healthadvances Posted on July 10, 2018 OCTANe’s Annual OTS 2018 Fuels Excitement in Novel Technologies in Ophthalmology Read More
by healthadvances Posted on July 9, 2018 Realizing the Power of Clinical and Consumer Genomics: Ethics, Business Models, and Regulatory Hurdles Read More
